The risk of VTE is greatest throughout the initial calendar year of usage of a COC and when restarting hormonal contraception after a break of four months or for a longer period. The chance of thromboembolic ailment on account of COCs slowly disappears immediately after COC use is discontinued. Figure 1 shows the risk of acquiring a VTE for women w